Neovasc Inc
TSX:NVCN
Neovasc Inc
Operating Income
Neovasc Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Neovasc Inc
TSX:NVCN
|
Operating Income
-$33.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-21%
|
|
Profound Medical Corp
TSX:PRN
|
Operating Income
-$29.3m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
Opsens Inc
TSX:OPS
|
Operating Income
-CA$12.5m
|
CAGR 3-Years
-86%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-19%
|
|
Nanalysis Scientific Corp
XTSX:NSCI
|
Operating Income
-CA$13.5m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Theralase Technologies Inc
XTSX:TLT
|
Operating Income
-CA$4.5m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-15%
|
|
MedMira Inc
XTSX:MIR
|
Operating Income
-CA$2.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-8%
|
CAGR 10-Years
3%
|
See Also
What is Neovasc Inc's Operating Income?
Operating Income
-33.2m
USD
Based on the financial report for Dec 31, 2022, Neovasc Inc's Operating Income amounts to -33.2m USD.
What is Neovasc Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-21%
Over the last year, the Operating Income growth was -19%. The average annual Operating Income growth rates for Neovasc Inc have been -4% over the past three years , -2% over the past five years , and -21% over the past ten years .